Regulation by differential development of Th1 and Th2 cells in peripheral tolerance to cardiac allograft induced by blocking ICAM-1/LFA-1 adhesion

Circulation

Volumn 96, Issue 7, 1997, Pages 2247-2253

  Isobe, Mitsuaki ^a   Suzuki, Jun Ichi ^b   Yamazaki, Satoshi ^b   Yazaki, Yoshikazu ^b   Horie, Shiro ^b   Okubo, Yoshio ^b   Maemura, Koji ^b   Yazaki, Yoshio ^b   Sekiguchi, Morie ^b  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Cytokines; Glycoproteins; Immune system; Immunology; Interleukins; Rejection; Transplantation

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCLONAL ANTIBODY; TACROLIMUS;

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CELL ADHESION; DRUG EFFECT; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; MALE; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL;

EID: 0030801836     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.7.2247     Document Type: Article

References (37)

1. Isobe M, Yagita H, Okumura K, Ihara A. Specific acceptance of cardiac allograft after treatment with anti-ICAM-1 and anti-LFA-1. Science. 1992;255:1125-1127.
2. Isobe M, Ihara A. Tolerance induction against cardiac allograft by anti-ICAM-1 and anti-LFA-1 treatment: T cells respond to in vitro allostimulation. Transplant Proc. 1993;25:1079-1080.
3. Mueller D, Jenkins M, Schwartz R. Clonal expansion versus functional clonal inactivation: a costimulatory outcome of T cell antigen receptor occupancy. Annu Rev Immunol. 1989;7:445-480.
4. van Seventer GA, Shimizu Y, Horgan KJ, Shaw S. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J Immunol. 1990;144:4579-4586.
5. Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion to different functional properties. Annu Rev Immunol. 1989;7:143-173.
6. Klamus SM, Falco DA, Villanueva JC, Rabkin J, Tomlanovich SJ, Vincenti F, Amend WJC, Melzer J, Garovoy MR, Roberts JP, Ascher NL, Matinez OM. Cytokine and T cell receptor gene expression at the site of allograft rejection. Transplantation. 1992; 53:151-156.
7. Romball CG, Weigle WO. In vivo induction of tolerance in murine CD4 cell subsets. J Exp Med. 1993;178:1637-1644.
8. O'Connell PJ, Pacheco SA, Nickerson PW, Muggia RA, Bastos M, Kelley VR, Strom TB. Unmodified pancreatic islet allograft rejection results in the preferential expression of certain T cell activation transcripts. J Immunol. 1993;150:1093-1104.
9. Dallman MJ, Larsen CP, Morris PJ. Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med. 1991;174:493-496.
10. Takeuchi T, Lowry RP, Konieczny B. Heart allografts in murine systems: the differential activation of Th2-like effector cells in peripheral tolerance. Transplantation. 1992;53:1281-1294.
11. Binder J, Hancock WW, Wasowska B, Gallon L, Watschinger B, Sayegh MH, Brock J, Lehmann M, Volk HD, Kupiec WJ. Donor-specific transplantation unresponsiveness in sensitized rats following treatment with a nondepleting anti-CD4 MAb is associated with selective intragraft sparing of Th2-like cells. Transplant Proc. 1995;27:114-116.
12. Sayegh MH, Akalin E, Hancock WW, Russell ME, Carpenter CB, Linsley. PS, Turka LA. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med. 1995;181:1869-1874.
13. Hofmann WJ, Dufter C, Terness P, Thies J, Post S, Otto G, Otto HF, Geisse T, Gaweco AS. Lack of preferential Th1/Th2 cytokine gene expression patterns in both alpha/beta T-cell-tolerant and -rejecting rat cardiac allografts. Transplant Proc. 1995;27:232-234.
14. Thai NL, Fu F, Qian S, Sun H, Gao L, Wang SC, Demetris AJ, Woo J, Thomson AW, Duquesnoy RJ, Fung JJ. Cytokine mRNA profiles in mouse orthotopic liver transplantation: graft rejection is associated with augmented TH1 function. Transplantation. 1995;59: 274-281.
15. Dallman MJ, Shiho O, Page TH, Wood KJ, Morris PJ. Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway. J Exp Med. 1991;173:79-87.
16. Nishimura T, Yagi H, Hashimoto Y. The role of lymphokine-activated cell-associated antigen, II: distribution and correlation with cell cycle. Cell Immunol. 1987;107:24-31.
17. Takei F. Inhibition of mixed lymphocyte response by a rat monoclonal antibody to a novel murine lymphocyte activation antigen (MALA-2). J Immunol. 1985;134:1403-1407.
18. Isobe M, Narula J, Strauss HW, Khaw BA, Haber E. Imaging the rejecting heart: in vivo detection of MHC class II antigen induction. Circulation. 1992;85:738-746.
19. Isobe M, Haber E, Khaw BA. Early detection of rejection and assessment of cyclosporine therapy by indium-111 antimyosin imaging in mouse heart allografts. Circulation. 1991;84:1246-1255.
20. Bogen SA, Fogelman I, Abbas AK. Analysis of IL-2, IL-4, and IFN-γ producing cells in situ during immune responses to protein antigens. J Immunol. 1993;150:4197-4205.
21. Morgan CJ, Pelletier RP, Hernandez CJ, Teske DL, Huang E, Ohye R, Orosz CG, Ferguson RM. Alloantigen-dependent endothelial phenotype and lymphokine mRNA expression in rejecting murine cardiac allografts. Transplantation. 1993;55:919-923.
22. Taylor PM, Rose ML, Yacoub MH, Pigott R. Induction of vascular adhesion molecules during rejection of human cardiac allografts. Transplantation. 1992;54:451-457.
23. Tanio JW, Basu CB, Albelda SM, Eisen HJ. Differential expression of the cell adhesion molecules ICAM-1, VCAM-1, and E-selectin in normal and posttransplantation myocardium: cell adhesion molecule expression in human cardiac allografts. Circulation. 1994; 89:1760-1768.
24. Isobe M, Suzuki J, Yagita H, Okumura K, Yamazaki S, Nagai R, Yazaki Y, Sekiguchi M. Immunosuppression to cardiac allografts and soluble antigens by anti-VCAM-1 and anti-VLA-4 monoclonal antibodies. J Immunol. 1994;153:5810-5818.
25. Lenschow DJ, Zeng Y, Thistlethwaite JR, Montag A, Brady W, Gibson MG, Linsley PS, Bluestone JA. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science. 1992; 257:789-792.
26. Turka AL, Linsley PS, Lin H, Brady W, Leiden JM, Wei RQ, Gibson ML, Zheng XG, Myrdal S, Gordon D. T cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci U S A. 1992;89:11102-11105.
27. Altmann D, Hogg N, Trowsdale J, Wilkinson D. Cotransfection of ICAM-1 and HLA-DR reconstitutes human antigen-presenting cell function in mouse L cells. Nature. 1989;338:512-514.
28. Geppert TD, Davis LS, Gur H, Wacholtz MC, Lipsky PE. Accessory cell signals involved in T-cell activation. Immunol Rev. 1990;117:5-66.
29. Cher DJ, Mosmann TR. Two types of murine helper T cell clones, II: delayed-type hypersensitivity is mediated by Th1 clones. J Immunol. 1987;138:3688-3694.
30. Fong TAT, Mossman TR. Alloreactive murine CD8+ T cell clones secrete the Th1 pattern of cytokines. J Immunol. 1990;144: 1744-1752.
31. Calne RY, Rolles K, White DJG, Thiru S, Evans DB, McMaster P, Dunne DC, Craddock GN, Henderson RG, Aziz S, Lewis P. Cyclosporine-A initially as the only immunosuppressant in 34 recipients of organs: 32 kidneys, 2 pancreases, 2 livers. Lancet. 1979;2:1033-1036.
32. Todo S, Fung JJ, Demetris AJ, Venkataramanan R, Startzl TE. Early trials with FK506 as primary treatment in liver transplantation. Transplant Proc. 1990;22:13-16.
33. Damle NK, Klussman K, Linsley PS, Aruffo A, Ledbetter JA. Differential regulatory effects of intercellular adhesion molecule-1 on costimulation by the CD28 counter-receptor B7. J Immunol. 1992;149:2541-2548.
34. Damle NK, Klussman K, Leytze G, Myrdal S, Aruffo A, Ledbetter JA, Linsley PS. Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7. J Immunol. 1994;152:2686-2697.
35. Kanner SB, Grosmaire LS, Ledbetter JA, Damle NK. Beta 2-integrin LFA-1 signaling through phospholipase C-gamma 1 activation. Proc Natl Acad Sci U S A. 1993;90:7099-7103.
36. Rudd CE, Janssen O, Cai YC, Silva AD, Raab M, Prasad KV. Two-step TCR zeta/CD3-CD4 and CD28 signaling in T cells: SH2/SH3 domains, protein-tyrosine and lipid kinases. Immunol Today. 1994;15:225-234.
37. Gajewski TF, Lancki DW, Stack R, Fitch FW. 'Anergy' of TH0 helper T lymphocytes induces downregulation of TH1 characteristics and a transition to a TH2-like phenotype. J Exp Med. 1994; 179:481-491.